Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
lactam antibiotic use in children on
pneumococcal resistance to penicillin: prospective cohort
study
Dilruba Nasrin a National
Centre for Epidemiology and Population Health, Australian National
University, Canberra, ACT 0200, Australia, b Infectious Diseases Unit and
Microbiology Department, Canberra Hospital, Canberra, c Department of General
Practice, Flinders University of South Australia, Adelaide, SA,
Australia Correspondence to: Dr Dilruba Nasrin, 9C-A Impiana
Condo, 1 Tasik Ampang, Jln Ulu Klang, Ampang 68000, Selangor, Malaysia nasrindilruba{at}hotmail.com
| |
Abstract |
|---|
|
|
|---|
Objective:
To examine the relation between use of
antibiotics in a cohort of preschool children and nasal carriage of
resistant strains of pneumococcus.
Design and participants:
Prospective cohort study
over two years of 461 children aged under 4 years living in Canberra, Australia.
Main outcome measures:
Use of drugs, respiratory
symptoms, and visits to doctors were documented in a daily diary by
parents of the children during 25 months of observation. Isolates of
pneumococci, which were cultured from nasal swabs collected
approximately six monthly, were tested for antibiotic resistance.
Results:
From the four swab collections 631 positive pneumococcal isolates from 461 children were found, of which
13.6% were resistant to penicillin. Presence of penicillin resistant pneumococci was significantly associated with children's use of a
lactam antibiotic in the two months before each swab collection (odds
ratio 2.03 (95% confidence interval 1.15 to 3.56, P=0.01)). The odds
ratio of the association remained >1 (though did not reach
significance at the 0.05 level) for use in the six months before swab
collection. The association was seen in children who received only
penicillin or only cephalosporin antibiotics in that period. The odds
ratio was 4.67 (1.29 to 17.09, P=0.02) in children who had received
both types of
lactam in the two months before their nasal swab. The
modelled odds of carrying penicillin resistant pneumococcus was 4%
higher for each additional day of use of
lactam antibiotics in the
six months before swab collection.
Conclusions:
Reduction in
lactam use could
quickly reduce the carriage rates of penicillin resistant pneumococci
in early childhood. In view of the propensity of these organisms to be spread among children in the community, the prevalence of penicillin resistant organisms may fall as a consequence.
|
What is already known on this topic
One possible cause of resistance is the excessive use of antibiotics in children with respiratory symptoms Few cross sectional studies have looked at the association between antibiotic use and subsequent carriage of organisms resistant to penicillin What this study adds
The likelihood of carrying penicillin resistant pneumococcus is doubled
in children who have used any The likelihood of a child carrying a penicillin resistant pneumococcus
is increased by 4% for each additional day of |
| |
Introduction |
|---|
|
|
|---|
The worldwide increase in pneumococcal resistance to
antibiotics is worrying.
1 2
An important contributor to
antibiotic resistance is the excessive use of antibiotics in young
children with respiratory symptoms.3 It is widely accepted
that antibiotic resistance is related to both the extent and amount of
antibiotics used. However, there are few prospective data to support
these presumptions. Carriage of resistant pneumococci in childhood has been associated with younger age, attendance at daycare centres, and
previous use of antibiotics.4-6 In our two year
prospective study in a community setting we studied the nasal carriage
of pneumococci, their sensitivity profile, and the intake of
antibiotics by preschool children in Canberra, Australia.
| |
Methods |
|---|
|
|
|---|
A cohort of 484 children from Canberra participated in the study from September 1997 to September 1999. General practitioners were first recruited into the study, then these doctors were asked to recruit the first 15 children who visited their practice for any reason. The parents of all participants kept a daily diary of the children's respiratory symptoms, visits to the doctor, and use of drugs, with detailed information on antibiotic use, including the name of the drug, duration of use, and the reason for taking it. Informed consent was obtained from the parents during recruitment. Nasal swabs were collected from the children up to four times over the 25 months of the study. Pneumococci were identified by colony characteristics and were tested for susceptibility to penicillin.7 The study period was divided into 12 periods of 60 days each. To limit misclassification of antibiotic use we considered only those children whose diary observations were complete for at least 75% of observation days. We also excluded from the main analysis swabs that were collected from children who were receiving continuous antibiotic therapy.
We defined penicillin as including penicillin V, amoxicillin, and
amoxicillin clavulate. Cephalosporin refers also to cefalexin and
ceclor. The term
lactam refers to either penicillin or cephalosporin.
We used two sided Fisher's exact tests for our univariate analyses and
multiple logistic regression models to model the odds of carriage of a
resistant organism. We accounted for correlation between repeated
observations on the same child.
8 9
We assessed a range of
covariates as possible confounders of the association between
antibiotic use and carriage of a resistant organism. A potential
confounder was entered into the logistic model if adjustment for the
variable resulted in a distortion of the odds ratio of
10%.10
| |
Results |
|---|
|
|
|---|
From the four nasal swab collections 631 pneumococcal
isolates from 461 children were found
37%, 46%, 39%, and 46% of
the swabs collected on each occasion (the higher percentages were from
the swabs collected in winter). Of the 631 pneumococcal isolates, 86 (13.6%) were resistant to penicillin, and six isolates were highly resistant.
Elsewhere we have described in detail the pattern of antibiotic resistance in the isolates collected from these children.11 Over half (334 (52.9%)) the isolates were resistant to at least one of the six antibiotics for which sensitivity was tested (penicillin, erythromycin, co-trimoxazole, tetracycline, chloramphenicol, and cefotaxime); 119 (18.9%) were resistant to two or more antibiotics; and 5 (0.8%) were resistant to all six.
Of the 631 pneumococcal isolates, 456 were collected from the children
whose diary records of drug treatment and medical visits were at least
75% complete in the six months before collection of the swab. Of these
isolates 68 (14.9%) were resistant to penicillin. These children took
lactam antibiotics for 0 to 85 days. Of the 456 isolates, 199 (43.6%) were from children with at least one day of
lactam use in
the previous six months. Over three quarters of the children (355 (76.9%)) received an antibiotic at some point in the two year study
period, and the overall mean period of antibiotic use per child per
year was 17.6 days.
To consider the relation between antibiotic use and resistance, we used
a logistic model to assess the odds of carrying a penicillin resistant
pneumococcal isolate against
lactam use in each two month period
before swab collection over the 24 months of the study. Age, sex,
number of siblings, type of day care, duration of day care, and any
hospital admission were assessed for their possible confounding
effects. The use of
lactam antibiotics in the two months before
swab collection was significantly associated with isolation of a
penicillin resistant pneumococcus, and the relation was not confounded
by the variables tested (adjusted odds ratio 2.03 (95% confidence
interval 1.15 to 3.56; P=0.01)). The odds ratio adjusted for the
clustering effect of multiple swabs in any one child was slightly >1
for
lactam prescriptions in the penultimate and last two month
periods before swabbing (odds ratios of 1.27 and 1.25, respectively),
but the 95% confidence intervals of these estimates included 1. If
children had received both a penicillin and a cephalosporin preparation
in the two month period before swabbing, the odds ratio of carrying a
resistant organism was 4.67 (1.27 to 17.09; P=0.02).
The percentages of penicillin resistant isolates were similar in the
group that had no
lactam use (12% (32/257)) and the group that had
only a relatively short course of
lactam (11% (7/64)), but this
percentage increased as the number of days of use increased beyond
seven days, to 26% (16/61) in children who had >14 days' use
(figure).
|
Although the children who received
lactam antibiotics for >7 days
in the six months before swab collection were more likely to carry a
penicillin resistant pneumococcus than the children who had not
received
lactam preparations in that period, this association was
significant only in children who had received >14 days of
lactam
(table).
|
We further explored the association between duration of
lactam use
and penicillin resistance by using duration of use as a continuous
rather than a categorical variable. Using a logistic regression model
adjusted for the effect of clustering within children, we found that
for each additional day of use in the six months before the swab
collection, the odds of a child carrying a penicillin resistant
pneumococcus increased by 4% (adjusted odds ratio 1.04 (1.01 to 1.06;
P=0.001)).
| |
Discussion |
|---|
|
|
|---|
Our results show that the likelihood of children carrying a
resistant organism is in the short term related to the amount of
lactam recently taken. Therefore if the amount of
lactam prescribed
could be reduced, it follows that selection and transmission of
resistant strains would occur less often.
Antibiotics are being overused in children of this age group in Australia. We found that 47% of all episodes of respiratory symptoms resulted in a visit to the general practitioner and that up to 48% of children who visited their general practitioner received an antibiotic on their first visit. Elsewhere we have examined the severity of symptoms in children who received antibiotics and those who did not receive them, and we did not find any difference between the two groups.11 This accords with the growing evidence from randomised controlled trials that the benefits of antibiotics in most early childhood respiratory illnesses are trivial or non-existent. 12 13 The likelihood that antibiotic use will, in the short term, result in carriage of a resistant organism needs to be built into clinical decision making.
A substantial reduction of
lactam use in preschool children could
quickly result in reduced carriage of penicillin resistant pneumococci.
A recent randomised trial compared dosages of 90 mg/day of amoxicillin
for five days and 40 mg/day for 10 days in children and found that the
higher dose of shorter duration was associated with lesser subsequent
carriage of resistant pneumococci.14
This supports our findings on the duration of
lactam
use. If these drugs are to retain their clinical usefulness, new
prescribing policies are needed in community practice.
| |
Acknowledgments |
|---|
We acknowledge the enthusiastic support of 50 general practitioners in Canberra and the parents of the children who participated in the study, and we thank Dr Rennie D'Souza for comments on an early manuscript and Anna Wilkinson for contacting parents.
Contributors: See bmj.com
| |
Footnotes |
|---|
Funding: The study was funded by research grants to RMD from the general practice evaluation programme of the Australian Department of Health and Aged Care and from SmithKline Beecham Pharmaceuticals to RMD.
Competing interests: None declared.
The full version of this article
appears on bmj.com
| |
References |
|---|
|
|
|---|
| 1. |
Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al.
Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).
Clin Infect Dis
1992;
15:
99-105 |
| 2. |
Turnidge JD, Bell JM, Collignon PJ.
Rapidly emerging antimicrobial resistance in Streptococcus pneumoniae in Australia.
Med J Aust
1999;
170:
152-155 |
| 3. |
Low DE, Scheld WM.
Strategies for stemming the tide of antimicrobial resistance.
JAMA
1998;
279:
394-395 |
| 4. |
Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F, et al.
Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.
JAMA
1998;
279:
365-370 |
| 5. |
Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Ernold JE, McDougal LK, et al.
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio.
J Infect Dis
1992;
166:
1346-1353 |
| 6. |
Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S.
Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.
BMJ
1996;
313:
387-391 |
| 7. | National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 5th informational supplement. Villanova, PN: NCCLS, 1994. (Document M100-S5.) |
| 8. | Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the 5th Berkeley symposium on mathematical statistics and probability. Berkeley, CA: University of California Press, 1967:1:221-33. |
| 9. |
White H.
Maximum likelihood estimates of misspecified models.
Econometrics
1982;
50:
1-25 |
| 10. | Hennekens CH, Buring JE. Epidemiology in medicine. 1st ed. Boston, MA and Toronto: Little, Brown, 1987. |
| 11. | Nasrin D. Effects of antibiotic use on respiratory illness and on antibiotic resistance in children [doctoral dissertation]. Canberra, Australia: Australian National University, 2000. |
| 12. |
Del Mar CB, Glasziou PP, Hayem M.
Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis.
BMJ
1997;
314:
1526-1529 |
| 13. | Del Mar C, Glasziou PP, Spinks P. Antibiotics for sore throat. Cochrane Database Syst Rev 2000;(2):CD000023 |
| 14. |
Schrag SJ, Pena C, Fernandez J, Sanchez J, Gomez V, Perez E, Feris JM, Besser RE.
Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial.
JAMA
2001;
286:
49-56 |
(Accepted 1 October 2001)
lactam use increases chance of children carrying penicillin resistant pneumococci
Read all Rapid Responses